JOURNAL OF BUON, vol.20, no.2, pp.479-486, 2015 (Peer-Reviewed Journal)
Article / Article
JOURNAL OF BUON
Science Citation Index Expanded, Scopus
Introduction: In lymph node-negative, hormone-positive, and Her2-negative breast cancer patients, the benefits of adding adjuvant chemotherapy to hormonal therapy continue to be debated, especially for low to intermediate grade and small tumors.